Miyamoto et al. [25] designed their clinical study as a randomized controlled cross-over trial to examine the effect of NMES training on metabolic parameters and the levels of the plasma brain-derived neurotrophic factor (BDNF) and the insulin-like-growth factor (IGF-1) in patients with T2DM. The gene discussed is IGF1; the disease is type 2 diabetes mellitus.